Insider Transactions Reported by 23 Insiders of Sagimet Biosciences Inc.

Symbol
SGMT on Nasdaq
Location
San Mateo, CA

Insiders trading volume in the past year

Sagimet Biosciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NEA Partners 13, Limited Partnership 10%+ Owner $12,301,128 29 Jan 2024
NEW ENTERPRISE ASSOCIATES 13 LP 10%+ Owner $12,301,128 29 Jan 2024
KPCB PBD Associates, LLC 10%+ Owner $7,787,848 18 Jul 2023
Jinzi Jason Wu Director $6,784,274 18 Jul 2023
David Happel President & CEO, Director $4,720,939 -$662,980 -12% 19 Feb 2026
Elizabeth Rozek Chief Legal & Admin. Officer $1,376,859 -$112,525 -7.6% 19 Feb 2026
Eduardo Bruno Martins Chief Medical Officer $863,154 -$95,118 -9.9% 19 Feb 2026
George Kemble Executive Chairman, Director $623,268 -$289,979 -32% 20 Nov 2025
Thierry Chauche Chief Financial Officer $349,771 -$7,033 -2% 19 Feb 2026
Patrick J. Kerins 10%+ Owner $53,870 29 Jan 2024
Merdad Parsey Director $52,455 05 Jun 2024
FOREST BASKETT 10%+ Owner $46,330 29 Jan 2024
Scott D. Sandell 10%+ Owner $28,688 29 Jan 2024
BETH C. SEIDENBERG Director 06 Jun 2025
Joseph Oriti Officer Title: Interim Principal Financial Officer. Exhibit 24 - Power of Attorney 01 Feb 2024
Timothy P. Walbert Director 09 Jun 2025
Richard J. Rodgers Director 18 Jul 2023
Anne M. Phillips Director 09 Jun 2025
Jennifer Jarrett Director 09 Jun 2025
ELIZABETH A. GRAMMER Director 09 Jun 2025
Dennis Hom Chief Financial Officer 18 Jul 2023
Anthony M. Rimac Chief Operating Officer 18 Jul 2023
Paul W. Hoelscher Director 09 Jun 2025

Recent Insider Transactions by Companies or Individuals for Sagimet Biosciences Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.